PortfoliosLab logoPortfoliosLab logo
MERC vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MERC vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mercer International Inc. (MERC) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MERC achieves a -63.32% return, which is significantly lower than ABBV's 4.43% return. Over the past 10 years, MERC has underperformed ABBV with an annualized return of -18.35%, while ABBV has yielded a comparatively higher 19.47% annualized return.


MERC

1D
-6.04%
1M
-30.17%
YTD
-63.32%
6M
-65.25%
1Y
-78.80%
3Y*
-53.70%
5Y*
-41.95%
10Y*
-18.35%

ABBV

1D
2.07%
1M
8.84%
YTD
4.43%
6M
4.29%
1Y
31.92%
3Y*
24.36%
5Y*
19.80%
10Y*
19.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MERC vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MERC
Mercer International Inc.
-63.32%-68.51%-28.65%-15.71%-0.59%19.46%-12.81%22.62%-24.32%39.65%
ABBV
AbbVie Inc.
4.43%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between MERC and ABBV is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.09

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (10Y)
Calculated over the trailing 10-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.16

Fundamentals

EPS

MERC:

-$10.51

ABBV:

$2.05

PS Ratio

MERC:

0.02

ABBV:

6.63

Total Revenue (TTM)

MERC:

$1.85B

ABBV:

$62.82B

Gross Profit (TTM)

MERC:

-$64.63M

ABBV:

$46.15B

EBITDA (TTM)

MERC:

-$73.03M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MERC vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MERC
MERC Risk / Return Rank: 44
Overall Rank
MERC Sharpe Ratio Rank: 44
Sharpe Ratio Rank
MERC Sortino Ratio Rank: 22
Sortino Ratio Rank
MERC Omega Ratio Rank: 33
Omega Ratio Rank
MERC Calmar Ratio Rank: 44
Calmar Ratio Rank
MERC Martin Ratio Rank: 77
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 7575
Overall Rank
ABBV Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 7575
Sortino Ratio Rank
ABBV Omega Ratio Rank: 7373
Omega Ratio Rank
ABBV Calmar Ratio Rank: 7474
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MERC vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mercer International Inc. (MERC) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MERCABBVDifference
Sharpe ratioReturn per unit of total volatility

-2.31

Sortino ratioReturn per unit of downside risk

-4.11

Omega ratioGain probability vs. loss probability

0.75

1.24

-0.48

Calmar ratioReturn relative to maximum drawdown

-0.95

1.85

-2.80

Martin ratioReturn relative to average drawdown

-1.44

4.11

-5.56

MERC vs. ABBV - Sharpe Ratio Comparison

The current MERC Sharpe Ratio is -1.04, which is lower than the ABBV Sharpe Ratio of 1.27. The chart below compares the historical Sharpe Ratios of MERC and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MERC vs. ABBV - Drawdown Comparison

The maximum MERC drawdown since its inception was -99.05%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for MERC and ABBV.


Loading charts...

Drawdown Indicators


MERCABBVDifference

Max Drawdown

Largest peak-to-trough decline

-99.05%

-45.09%

-53.96%

Max Drawdown (1Y)

Largest decline over 1 year

-83.34%

-17.32%

-66.02%

Max Drawdown (3Y)

Largest decline over 3 years

-92.89%

-20.74%

-72.15%

Max Drawdown (5Y)

Largest decline over 5 years

-95.26%

-21.92%

-73.34%

Max Drawdown (10Y)

Largest decline over 10 years

-95.26%

-45.09%

-50.17%

Current Drawdown

Current decline from peak

-96.25%

-1.66%

-94.59%

Average Drawdown

Average peak-to-trough decline

-61.20%

-10.70%

-50.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.53%

7.78%

+46.75%

Volatility

MERC vs. ABBV - Volatility Comparison

Mercer International Inc. (MERC) has a higher volatility of 24.45% compared to AbbVie Inc. (ABBV) at 9.26%. This indicates that MERC's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MERCABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

24.45%

9.26%

+15.19%

Volatility (6M)

Calculated over the trailing 6-month period

56.24%

19.11%

+37.13%

Volatility (1Y)

Calculated over the trailing 1-year period

75.71%

25.23%

+50.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

52.66%

23.12%

+29.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.42%

25.83%

+22.59%

Dividends

MERC vs. ABBV - Dividend Comparison

MERC's dividend yield for the trailing twelve months is around 10.33%, more than ABBV's 2.87% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.87%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
MERC
Mercer International Inc.
10.33%7.58%4.62%3.16%2.58%2.17%3.24%4.37%4.79%3.29%4.32%2.54%

Financials

MERC vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Mercer International Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
489.30M
15.00B
(MERC) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

MERC vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Mercer International Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%202220232024202520260
83.5%
Portfolio components
MERC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mercer International Inc. reported a gross profit of 0.00 and revenue of 489.30M. Therefore, the gross margin over that period was 0.0%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

MERC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mercer International Inc. reported an operating income of -32.89M and revenue of 489.30M, resulting in an operating margin of -6.7%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

MERC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mercer International Inc. reported a net income of -52.00M and revenue of 489.30M, resulting in a net margin of -10.6%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


MERC and ABBV have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MERC has higher volatility (24.45%) compared to ABBV (9.26%). In terms of maximum drawdown, MERC dropped -99.05% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.27 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MERC and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer